NASDAQ:MYL - Mylan Stock Price, Forecast & News

Mylan trades on the NASDAQ under the ticker symbol "MYL."

Mylan NV (NASDAQ:MYL) announced its earnings results on Tuesday, November, 5th. The company reported $1.17 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.14 by $0.03. The company earned $2.96 billion during the quarter, compared to analyst estimates of $3.01 billion. Mylan had a return on equity of 18.80% and a net margin of 0.42%. The firm's quarterly revenue was up 3.5% compared to the same quarter last year. During the same period last year, the company posted $1.25 earnings per share. View Mylan's Earnings History.

Mylan is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Mylan.

Mylan updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided EPS guidance of $4.20-4.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.27. The company issued revenue guidance of $11.5-12.0 billion, compared to the consensus revenue estimate of $11.61 billion.

18 brokers have issued 1 year target prices for Mylan's shares. Their forecasts range from $18.00 to $36.00. On average, they expect Mylan's share price to reach $27.26 in the next twelve months. This suggests a possible upside of 25.9% from the stock's current price. View Analyst Price Targets for Mylan.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mylan in the last year. There are currently 7 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Mylan.

News coverage about MYL stock has been trending somewhat negative recently, InfoTrie reports. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Mylan earned a media sentiment score of -1.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Mylan.

Mylan saw a decrease in short interest in December. As of December 31st, there was short interest totalling 19,680,000 shares, a decrease of 17.3% from the December 15th total of 23,800,000 shares. Based on an average daily volume of 6,520,000 shares, the days-to-cover ratio is currently 3.0 days. Currently, 3.8% of the company's shares are sold short. View Mylan's Current Options Chain.

Some companies that are related to Mylan include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR), Zogenix (ZGNX) and Pacira Biosciences (PCRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Mylan investors own include Gilead Sciences (GILD), Teva Pharmaceutical Industries (TEVA), Alibaba Group (BABA), Allergan (AGN), Micron Technology (MU), Starbucks (SBUX), Netflix (NFLX), NVIDIA (NVDA), Intel (INTC) and General Electric (GE).

Mylan's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Commerzbank Aktiengesellschaft FI (0.07%), State of Alaska Department of Revenue (0.03%), Alpine Global Management LLC (0.02%), Nisa Investment Advisors LLC (0.01%), Cumberland Advisors Inc. (0.01%) and Zeke Capital Advisors LLC (0.00%). Company insiders that own Mylan stock include Anthony Mauro, Goulds Bruce, Melina E Higgins, Paul Campbell, Rajiv Malik, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt. View Institutional Ownership Trends for Mylan.

MYL stock was sold by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, Nisa Investment Advisors LLC, State of Alaska Department of Revenue and Zeke Capital Advisors LLC. View Insider Buying and Selling for Mylan.

MYL stock was acquired by a variety of institutional investors in the last quarter, including Alpine Global Management LLC, Altfest L J & Co. Inc., Cumberland Advisors Inc. and Huntington National Bank. Company insiders that have bought Mylan stock in the last two years include Melina E Higgins, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt. View Insider Buying and Selling for Mylan.

Shares of MYL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MYL stock can currently be purchased for approximately $21.66.

Mylan has a market capitalization of $11.18 billion and generates $11.43 billion in revenue each year. The company earns $352.50 million in net income (profit) each year or $4.58 on an earnings per share basis. Mylan employs 35,000 workers across the globe.View Additional Information About Mylan.

The official website for Mylan is http://www.mylan.com/.

Mylan's mailing address is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. The company can be reached via phone at 724-514-1800 or via email at [email protected]